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Abstract
Background & objectives: The pregnant woman is more prone to malaria than her non-pregnant coun-
terpart with grave consequences for both mother and baby.  This study aims at determining the ma-
laria prevention practices among pregnant women in an area hyper-endemic for malaria.
Methods: For the study  983 parturient mothers were enrolled in Ibadan, southwest Nigeria. Information
was collected on sociodemographic characteristics, use of malaria chemoprophylaxis, use of anti-vector
measures, and malaria parasitaemia.
Results: Most mothers [956/972 (98.4%)] reported the use of anti-vector measures for malaria pre-
vention. These include, window screens  (78.9%), insecticides spray (69.9%), mosquito coils  (25.3%),
untreated bednets  (2.5%), and insecticide-treated nets (1.1%). Most mothers used anti-vector mea-
sures either singly or in combination.  About 86%  (840/972) of the mothers used drugs for chemo-
prophylaxis. Thirteen (1.3%) mothers used chemoprophylaxis alone (CP), 135 (13.9%) used anti-
vector measures alone (AV) while 820 (84.4%) used chemoprophylaxis plus anti-vector (CPAV).
Weekly dose of pyrimethamine [214 (25%)] and intermittent preventive treatment with sulphadoxine-
pyrimethamine [598 (71.2%)] were the widely used chemoprophylactic drugs. The prevalence of patent
parasitaemia at delivery was 7.7% (1/13), 12.1% (99/820) and 16.3% (22/135) among CP, CPAV and
AV groups respectively. Geometric mean parasite densities among the respective groups were
7840/μl, 1228/μl and 8936/μl.
Conclusion: Window screens and insecticide sprays were widely used for malaria prevention while
the use of ITN was very low among enrolled mothers. There is a need to pay concerted efforts to im-
prove ITN usage rate in Nigeria.
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Introduction
Malaria infection during pregnancy is a major pub-
lic health problem as it predisposes to adverse preg-
nancy outcomes which include abortion, premature
delivery, small for date  babies, maternal anaemia and
even intrauterine death of the fetus in some cases1.
Pregnancy increases the risk of malaria in women by
reducing their immunity to malaria2. This reduction
in immunity tends to be more severe in primigravidae
than in multigravidae and results in more frequent
episodes of parasitaemia and a greater severity of
malaria fever in pregnant women3. It is, therefore, im-
portant for the pregnant woman to be protected fromJ  VECTOR  BORNE  DIS  45, SEPTEMBER 2008 218
contacting the infection. Prevention of malaria en-
compasses a variety of measures that may protect
against being bitten by the disease vector or against
the development of disease in infected individuals4.
Based on the available evidence, World Health Or-
ganization (WHO) recommends a three-pronged ap-
proach to the prevention and management of malaria
during pregnancy: insecticide-treated nets (ITNs); in-
termittent preventive treatment with sulphadoxine-
pyrimethamine5 and effective case management of
malaria illness. In addition to ITNs, other protective
measures at household level include protective cloth-
ing, insect repellents, bednets (plain or insecticide-
treated nets) and spraying of insecticides. Large-scale
spraying of insecticides and environmental manage-
ment are other control measures at the community
level.
Although insecticide-treated bednets and curtains
have emerged in recent years as promising tools, their
use in Africa is limited6. Various studies have shown
that ITN is effective in the control of malaria in preg-
nant women7,8. D’Alessandro et al7 demonstrated that
the use of ITNs significantly reduced the number of
primigravidae with parasitaemia in villages where it
was used compared to control villages. The study by
ter Kuile et al8 also showed that women who used
ITN had significantly fewer pre-term deliveries and
babies with higher mean birth weight than women
who did not use ITN.
For many years antimalarial chemoprophylaxis with
weekly dose of pyrimethamine or chloroquine was
recommended for pregnant women in endemic are
as to prevent the adverse effects of malaria in preg-
nancy9. Emphasis was also placed on case manage-
ment of the clinical disease with chloroquine. Poor
compliance and emergence of drug resistant strains
of Plasmodium falciparum have however compro-
mised the efficacy of these regimens10,11. The use of
intermittent preventive treatment (IPTp) with a potent
antimalarial drug in pregnant women has been shown
to be effective in preventing malaria in pregnancy as
well as improving pregnancy outcome12–14. The
WHO has consequently adopted IPTp with sulpha-
doxine-pyrimethamine as the gold standard for pre-
vention of malaria in pregnancy15.
This study reports the pattern of malaria preventive
measures during pregnancy among parturient women
in southwestern Nigeria, hyperendemic for malaria.
Material & Methods
The study was conducted at St. Mary’s Catholic Hos-
pital, Eleta in Ibadan, southwest Nigeria between
May 2003 and October 2004 as part of a larger study
evaluating the epidemiology of congenital malaria16.
Ethical approval for the study was provided by the
University of Ibadan/University College Hospital and
the University of Boston Institutional Review Com-
mittees. Malaria preventive practices and the associ-
ated factors among 983 mothers were examined.
Questionnaires were administered by trained research
assistants to mothers delivering in the study hospital
to collect information on sociodemographic factors
and malaria prevention measures used during the
index pregnancy. Thick blood smears were prepared
from finger prick blood samples from the parturient
mothers. Blood smears were air-dried and stained
with freshly prepared 10% Giemsa stain at pH 7.2.
Blood smears were examined under x100 oil im-
mersion lens of a light microscope for detection and
quantification of malaria parasitaemia. Malaria diag-
nosis was based on the identification of asexual
stages of Plasmodium in thick blood smears. Parasite
densities were calculated using an assumed leukocyte
count of 8000/μl17.
Data analysis:  Data collected were double-entered
using the Epi info software version 6.04 (CDC, At-
lanta) and were transferred to the Statistical Package
for the Social Sciences (SPSS Inc., Chicago, IL,
U.S.A.) for further analysis. Frequency tables and
graphs were generated for relevant variables. De-
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tions were used to summarize quantitative variables
while qualitative variables were summarized with
proportions. The χ2 test was used to investigate asso-
ciations between two qualitative variables. Analysis
of variance was used to compare more than two mean
values. All analyses were done at the 5% level of
significance.
Results
The mean age of the mothers was 29.6 yr + 5.2 with
a range of 17–44 yr. The mean gravidity was 3.0 + 1.7
with a range of 1–10 while mean parity was 6 + 1.83
with a range of 0–7. Table 1 shows details of demo-
graphic characteristics of the mothers.
Table 1.  Malaria prevention by selected variables
Patient characteristics            Use of malaria prevention measures  p-value
Yes  (%)    No (%) Total no. (%)
Occupation
Senior civil servants/Professionals 132 (13.9) 2 (12.5) 134 (13.9)
Intermediate civil servants/Senior teachers 88 (9.3) 1 (6.3) 89 (9.2)
Junior school teachers/Artisans 185 (19.5) 4 (25) 189 (19.6) 0.97
Petty traders/Labourers 462 (48.6) 8 (50) 470 (48.7)
Students/Unemployed/Housewives/Farmers 83 (8.7) 1 (6.3) 84 (8.7)
Total 950 16 966
Age group (yr)
10–20 26 (2.7) 2 (11.1) 27 (2.7)
21–30 553 (57) 2 (11.1) 555 (56.2) 0.13
31–40 379 (39.1) 9 (50) 388 (39.3)
41–50 12 (1.2) 5 (27.8) 17 (1.7)
Total 970 18 987
Mother’s education
None/Pry/Quranic 143 (15) 5 (1.3) 148 (15.3) 0.08
Sec/Post-sec 810 (85) 11 (68.8) 821 (84.7)
Total 953 16 969
Gravidity
1 221 (23.1) 6 (37.5) 227 (23.4)
2 210 (22) – 210 (21.6) 0.01*
3–4 346 (36.2) 3 (18.8) 349 (35.9)
>4 178 (18.6) 7 (43.8) 185 (19.1)
Total 955 16 971
Parity
0 219 (23.1) 6 (37.5) 225 (23.3)
1 233 (24.5) 2 (12.5) 235 (24.3) 0.23
2–3 362 (38.1) 4 (25) 366 (37.9)
>3 136 (14.3) 4 (25) 140 (14.5)
Total 950 16 966
*Significant at 5%.J  VECTOR  BORNE  DIS  45, SEPTEMBER 2008 220
Anti-vector malaria preventive measures: Nine hun-
dred and fifty-six of 972 (98.4%) mothers who re-
sponded to the question on the use of anti-vector
measures to prevent malaria responded in the affir-
mative while 16 (1.6%) said they did not. Eleven of
983 (1.1%) enrolled mothers did not respond to the
question. One hundred and thirty-five (13.9%) used
anti-vector measures alone (AV) while 820 (84.4%)
used it in combination with chemoprophylaxis
(CPAV). Seven hundred and sixty-six (78.8%) re-
spondents used window mosquito screens, 679
(69.9%) insecticide sprays, 246 (25.3%) mosquito
coils, 24 (2.4%) untreated bednets, while 11 (1.1%)
reported the use of ITN (Fig. 1). Most of the moth-
ers used anti-vector measures in various combina-
tions with a large proportion using mosquito screens
plus insecticide sprays (540/971; 55.6%). Details of
the different combinations of anti-vector measures
used are shown in Table 2.
The level of education, type of occupation, age and
parity of mothers did not influence the choice of anti-
vector measure (Table 1). However, gravidity was
statistically significantly associated with the use of
anti-vector measures (p < 0.01). About a third (346/
955; 36.2%) of mothers who used anti-vector mea-
sures had a gravidity of 3–4, while 178 (18.6%) had
a gravidity of greater than four. Overall, mother’s
education was not significantly associated with ma-
laria prevention (Table 1). Table 1 also shows malaria
Fig. 1: Pattern of anti-vector measures used by parturient
women in Ibadan, Southwest Nigeria
Table 2. Anti-vector measures combinations, parasitaemia and birth weight
Type of combination No. of user/ Percentage Mean parasite Mean birth
No. interviewed (%) positive for malaria density  (/μl)* weight + SD  (g)
ITN plus screen 7/983 (0.7) – – 3008 + 615.2
ITN plus coil 4/983 (0.4) 1/4 (0.25) 6269 2937.5 + 675
Repellent plus spray 1/971 (0.1) 1/1 (100) 480 4000
Bednet plus repellent 1/971 (0.1) 0/1 (0) – 3000
Coil plus repellent 3/971 (0.3) 0/3 (0) – 2583.3 + 425.2
Screen plus repellent 3/971 (0.3) 1/3 (33.3) 480 3050 + 926
Bednet plus coil 4/972 (0.4) 0/4 (0) – 3125 + 250
Bednet plus screen 13/972 (1.3) 0/13 (0) – 3053 + 390
Bednet plus spray 13/972 (1.3) 0/13 (0) – 3076.9 + 311.3
Screen plus coil 147/971 (15.1) 17/147 (11.6) 1423 3117 + 498.2
Screen plus spray 540/971 (55.6) 59/540 (10.9) 1088 3197.7 + 504
Screen plus coil plus spray 75/971 (7.7) 11/75 (14.7) 869 3173.3 + 405.5
*Geometric means are presented.
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prevention by some selected variables. One of 11
mothers who used ITNs had patent parasitaemia
while 90/766 (11.7%) who used mosquito screen had
patent parasitaemia with a geometric mean parasite
density of 1323/μl of blood and mean birth weight
of the babies was 3181 + 532.6 g. However, none of
the bednet users had patent parasitaemia and the
mean birth weight of the babies was 2987 + 403.1 g.
Table 3 shows the malaria positivity and mean birth
weights of babies in each group for the various anti-
vector combinations.
Pattern of chemoprophylaxis use: A total of 840
mothers (85.6%) reported the use of antimalarial
drugs for chemoprophylaxis while 141 (14.4%) did
not. Of these, 598 (71.2%) used SP-IPT, 214 (25.5%)
used pyrimethamine, 23 (2.7%) used chloroquine
while only one (0.1%) used proguanil (Table 4). The
effectiveness of these drugs in the prevention of
maternal and placental malaria has been reported in
another publication14. Thirteen mothers (1.3%) used
chemoprophylaxis (CP) alone, while 820 (84.4%) used
a combination of chemoprophylaxis and anti-vector
measures (CPAV). Of the 13 who used chemoprophy-
laxis alone, seven of them used SP-IPT, five used py-
rimethamine while the remaining one did not report
the type of chemoprophylaxis used.
Patent malaria parasitaemia: The prevalence of
patent parasitaemia among the mothers at delivery
was 7.7% (1/13), 16.3% (22/135) and 12.1% (99/
820) for CP, AV and CPAV respectively (p>0.05).
The geometric mean parasite densities among CP,
AV and CPAV were 7840/μl, 8936/μl and 12278/μl
respectively (p>0.05) while mean birth weight
were 2965.4 + 268.8, 3054.5 + 502.9 and 3176.9 +
530.8 g in the three groups respectively (p < 0.001).
Thirty-four of 214 (15.9%) mothers that used
pyrimethamine had patent parasitaemia while 62
of 598 (10.4%) mothers that received IPT with
sulphadoxine-pyrimethamine (SP-IPT), had patent
parasitaemia (p < 0.05).  Table 4 shows the relation-
ship between type of drug used for chemoprophylaxis
and patent malaria parasitaemia.
Table 3. Type of single anti-vector measures, malaria positivity, birth weight and parasite densities
Anti-vector measures No. (%) Maternal malaria Mean parasite Mean birth
  positive (%)  density (/μl)*  weight + SD (g)
Mosquito screens 766 (78.8) 90/766 (11.7) 1323 3180.5 +532.6
Insecticide sprays 679 (69.9) 84/679 (12.4) 1037 3169.7 +502.4
Mosquito coils 246 (25.3) 36/246 (14.6) 1326 3097.9 +499.2
Herbs 65 (6.6) 7/65 (10.8) 2163 3095.4 +502.6
Untreated bednets 24 (2.4) 0/24 (0) – 2987.5 +403.1
ITNs 11 (1.1)  1/11 (9.1) 6269 3040 +597.8
Repellents 5 (0.5) 1/5 (20) 480 2950 +683.7
*Geometric means are presented.
Table 4. Type of chemoprophylaxis by malaria
parasitaemia
Type of Malaria parasitaemia Total no. of
chemopro- mothers
phylaxis Negative (%) Positive (%) (%)
SP-IPT 536 (89.6) 62 (10.4) 598 (71.2)
Pyrimethamine 180 (84.1) 34 (15.9) 214 (25.5)
Chloroquine 21 (91) 2 (9) 23 (2.7)
Herbs 3 (75) 1 (25) 4 (0.5)
Proguanil 1 (100) 0 1 (0.1)
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Discussion
Vector control can significantly contribute to reduc-
ing the risk of malaria infection provided that it is
well-planned, targeted and timely. This study showed
that majority of mothers delivering in the study hos-
pital in urban southwestern Nigeria used chemopro-
phylaxis and/or anti-vector measures for prevention
of malaria during pregnancy with a large proportion
combining both methods. The study also revealed
that a wide variety of anti-vector measures such as
window screens, insecticide sprays, mosquito coils,
untreated bednets and ITNs were used. Although ITN
has been shown to be effective in the control of ma-
laria in pregnant women7,8, its use among pregnant
women in this study was very low (1.1%).  This find-
ing is consistent with another report from rural south-
west Nigeria which showed that majority of people
in the rural areas used screens and sprays to protect
against malaria while the use of ITN was poor18. The
reported low rate of ITN use in southwest Nigeria
underscores the need to address the use of ITN.
The promotion of ITN in Nigeria requires careful
consideration, more so when the initial cost of pur-
chase of the net is often out of reach of the most vul-
nerable persons in endemic areas. Ideally, the Federal
Government of Nigeria should make ITN available at
highly subsidized rate especially to very young chil-
dren and pregnant women who are particularly vul-
nerable to malaria and its deleterious effects. Failing
this, soliciting the assistance of international agencies
in funding large-scale procurement and distribution
of ITN is a viable option which malaria control bod-
ies in Nigeria may wish to pursue. Insecticide-treated
nets (ITNs) are estimated to be twice as effective as
untreated nets6 and offer > 70% protection compared
with no net19. A lower proportion of mothers who
used a combination of anti-vector measures and
chemoprophylaxis (12.1%) had patent malaria para-
sitaemia compared with mothers who used anti-vec-
tor measures only (16.3%). Mothers who used
chemoprophylaxis alone recorded the lowest preva-
lence of patent parasitaemia when compared to the
AV and CPAV groups.  These differences were how-
ever not statistically significant. The expected advan-
tage in the prevention of maternal parasitaemia by
combining chemoprophylaxis and anti-vector mea-
sures when compared to the CP and AV groups did
not reach a level of significance in this study most
probably because most (71.2%) of the mothers en-
rolled in this study received the highly effective SP-
IPT for malaria prevention. This might also explain
why they had lower parasitaemia compared to the
other groups. Our results showed a complete absence
of parasitaemia in the untreated bednet users and also
those who used it in combination with other mea-
sures. This supports the findings of Bradley et al20
that the use of untreated bednets may protect from
malaria. Safekui-Noubissi et al21 also showed that the
use of bednets whether treated or not protects against
severe malaria.  In contrast to the poor usage rate of
ITN, a large proportion of parturient women in this
study received IPTp with sulphadoxine-pyrimeth-
amine, the current drug of choice in the prevention of
malaria in pregnancy.  This can be explained by the
fact that SP-IPT was administered and supervised at
the antenatal clinic,  while the choice and use of anti-
vector measures depended on the disposition of the
individual, affordability and perception.
The findings of this study highlight a high level of
awareness on the use of malaria preventive measures
by pregnant women attending a secondary urban
health facility in southwest Nigeria. This is good for
the success of the Global Malaria Control and the
RBM strategies which propose to reduce malaria
morbidity and mortality among pregnant women.
However, the low usage rate for ITNs despite the fact
that it is part of the package provided in antenatal
clinic is a major concern. This suggests that the vari-
ous interventions for use of ITNs have not been very
effective. The possible causes for this failure need
urgent exploration and must be addressed. The value
of health education for the pregnant woman on the
importance of preventing malaria during antenatalYUSUF et al: MALARIA PREVENTIVE PRACTICES AMONG PREGNANT WOMEN  223
clinics can not be overemphasized. Efforts at creat-
ing awareness should be intensified and the use of
ITNs emphasized. The national malaria control unit
through the health facilities should promote the use
of ITNs as done for SP and the factors mitigating
against its use should be circumvented in order to
achieve optimal pregnancy outcome  which would
translate to improved health of mothers and new-
borns.
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